Also trades as: THYROCARE.NS (NSE) · $vol 4M

₹536.00 ($5.57)

+1.65 (+0.31%)

BSE · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 35 · ₹85.3B mcap · 46M float · 0.182% daily turnover

Revenue

$8.3B +20.6% ▲

5Y CAGR: +10.9%

Gross Profit

$3.1B -37.6% ▼

5Y CAGR: -1.3%

Operating Income

$2.1B +53.1% ▲

5Y CAGR: +8.0%

Net Income

$1.6B +78.2% ▲

5Y CAGR: +7.6%

EPS (Diluted)

$10.24 -40.6% ▼

5Y CAGR: -13.7%

EBITDA

$2.7B +30.3% ▲

5Y CAGR: +7.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$5.9B	$5.3B	$5.7B	$6.9B	$8.3B
YoY Growth	+19.1%	-10.6%	+8.6%	+20.2%	+20.6%
Cost of Revenue	$1.7B	$1.6B	$3.9B	$1.9B	$5.2B
Gross Profit	$4.2B	$3.6B	$1.8B	$5.0B	$3.1B
Gross Margin	71.2%	69.0%	31.6%	72.2%	37.4%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$395M	$435M	$657M	$774M	$942M
Operating Expenses	$2.2B	$2.8B	$850M	$3.6B	$1.0B
Operating Income	$2.0B	$866M	$958M	$1.4B	$2.1B
Operating Margin	34.1%	16.4%	16.8%	19.7%	25.0%
Interest Expense	$24M	$48M	$55M	$30M	$28M
Income Before Tax	$2.3B	$886M	$956M	$1.5B	$2.1B
Tax Expense	$516M	$242M	$265M	$547M	$500M
Net Income	$1.8B	$645M	$708M	$915M	$1.6B
Net Margin	29.9%	12.2%	12.4%	13.3%	19.7%
EPS (Diluted)	$33.24	$12.14	$13.34	$17.23	$10.24
EBITDA	$2.6B	$1.3B	$1.5B	$2.0B	$2.7B
Shares Outstanding	53M	53M	53M	54M	159M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$1.6B	$1.8B	$1.7B	$1.9B	$1.9B	$2.2B	$2.0B	$2.2B
Cost of Revenue	$855M	$936M	$452M	-$332M	$556M	$1.0B	$1.0B	$1.1B
Gross Profit	$714M	$838M	$1.2B	$2.2B	$1.4B	$1.1B	$909M	$1.2B
Gross Margin	45.5%	47.3%	72.8%	117.7%	71.2%	51.6%	46.5%	52.3%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$401M	$486M	$0	$212M	$466M	$519M	$547M	$561M
Operating Expenses	$401M	$486M	$961M	$930M	$910M	$519M	$547M	$561M
Operating Income	$313M	$352M	$247M	$439M	$464M	$598M	$362M	$611M
Operating Margin	19.9%	19.9%	14.9%	23.5%	24.0%	27.6%	18.5%	27.3%
Interest Expense	$10M	$8M	$6M	$7M	$8M	$6M	$0	$15M
Income Before Tax	$336M	$368M	$279M	$472M	$505M	$626M	$354M	$644M
Tax Expense	$96M	$104M	$90M	$256M	$122M	$148M	$73M	$157M
Net Income	$242M	$267M	$191M	$217M	$390M	$480M	$290M	$471M
Net Margin	15.4%	15.0%	11.5%	11.6%	20.2%	22.2%	14.8%	21.0%
EPS (Diluted)	$4.51	$4.98	$3.56	$4.16	$7.33	$9.06	$1.81	$2.98
EBITDA	$463M	$506M	$457M	$623M	$627M	$744M	$567M	$800M
Shares Outstanding	54M	54M	54M	52M	53M	53M	160M	158M

THYROCARE.BO BSE